Clinical Trials
14 trialsNCT05949632 2026-06-04
A Study of INCB099280 in Combination With Axitinib in Adults With Advanced Solid Tumors
Incyte Corporation
Phase 1/2 Terminated
NCT02834013 2026-06-03
Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
National Cancer Institute (NCI)
Phase 2 Active not recruiting
NCT04814108 2026-03-18
A Study of Azenosertib (ZN-c3) in Women With Recurrent or Persistent Uterine Serous Carcinoma
K-Group, Beta, Inc., a wholly owned subsidiary of Zentalis Pharmaceuticals, Inc
Phase 2 Completed
NCT03673124 2025-12-23
Ribociclib and Letrozole Treatment in Ovarian Cancer
GOG Foundation
Phase 2 Active not recruiting
NCT02101788 2025-11-13
Trametinib in Treating Patients With Recurrent or Progressive Low-Grade Ovarian Cancer or Peritoneal Cavity Cancer
National Cancer Institute (NCI)
Phase 2/3 Completed
NCT04159155 2025-08-12
CAN-STAMP
University Health Network, Toronto
Phase 2/3 Terminated
NCT04458597 2025-08-01
Stereotactic Pelvic Adjuvant Radiation Therapy in Cancers of the Uterus.
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
Phase NA Completed
NCT04575961 2025-05-23
PERCEPTION
North Eastern German Society of Gynaecological Oncology
Phase 2 Active not recruiting
NCT05289648 2024-12-19
NIREC
Sir Mortimer B. Davis - Jewish General Hospital
Phase EARLY_PHASE1 Withdrawn
NCT04716686 2024-01-05
Niraparib Monotherapy as Maintain and Recurrent Treatment of Endometrial Serous Carcinoma
Shandong University
Phase 2 Recruiting
NCT00551070 2020-12-03
Selumetinib Sulfate in Treating Woman With Recurrent Low-Grade Ovarian Cancer or Peritoneum Cancer
National Cancer Institute (NCI)
Phase 2 Completed
NCT03150121 2020-02-26
BEDOCA
Sheba Medical Center
Phase NA Unknown
NCT04055038 2019-08-13
EPITOC
Blokhin's Russian Cancer Research Center
Phase 2/3 Unknown
NCT00515073 2014-07-03
Papillary Serous Carcinoma of the Endometrium
M.D. Anderson Cancer Center
Phase 2 Completed